Logo from ESR

ESR applies to list logistics REIT on the Shanghai Stock Exchange

The REIT will handle three projects in Kunshan, Jiangsu Province.

ESR has submitted its application to list its three high-standard logistics projects through a REIT on the Shanghai Stock Exchange (SSE).

The three projects are in Kunshan, Jiangsu Province.

In a bourse filing in Hong Kong, ESR said it also applied for and has been granted a waiver from strict compliance with the requirement of having "due regard to the interests of its existing shareholders by providing them with an assured entitlement to shares in the spun-off entity, either by way of a distribution in specie of existing shares in the spun-off entity or by way of preferred application in any offering of existing or new shares in the spun-off entity."

The company said it is not feasible for them to comply with the requirements given "PRC legal impediments."

Follow the link for more news on

Join Hong Kong Business community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

Hong Kong and Shanghai to enhance financial ties
The two cities will leverage on their competitive advantage to boost their financial cooperation.
HK Express load factors exceed 97% in April amidst Easter holidays
Current bookings to North Asian destinations exceed 90% occupancy as Golden Week approaches.
Aviation
PolyU partners with ZEISS for myopia control tech advancement
The partnership focuses on developing myopia control and other ophthalmic technologies.
Healthcare